Legal Representation
Attorney
Norm J. Rich
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 19, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 19, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 26, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 24, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 24, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 24, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 8, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 6, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 6, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 6, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 18, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 21, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 21, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 1, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 16, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 10, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 3, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 24, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005